NHKãã¥ãŒã¹ã®æãèµ·ããïŒãã³ããã¯ã¯ãã³ã®è¿œå æ¥çš®ã¯ç¶ããã©ããŸã§ã!?
NHKããã¢ã³ãœããŒã»ãã¡ãŠãæ°ãžã®ç¬å ã€ã³ã¿ãã¥ãŒãè¡ã£ããšããèšäºããããŸããã圌ã¯ãæšå¹Ž12æã«ã¢ã¡ãªã«ã®åœç«ã¢ã¬ã«ã®ãŒææçç ç©¶æïŒNIAIDïŒæé·ãéä»»ããŠããŸããNHKã¯ãªããã®ã¿ã€ãã³ã°ã§ã€ã³ã¿ãã¥ãŒãã圌ã®çºèšãåœæ°ã«ç¥ãããã®ã§ããããïŒãNHKãå ±ããŠããã圌ã«é¢ããéå»ã®èšäºãæãèµ·ãããŠã¿ãŸããã
ã察çãšããŠã¯ã¯ã¯ãã³æ¥çš®ãæãæå¹ã
以äžãNHKãã¥ãŒã¹ããã®åŒçšã§ãã
ç±³ ãã¡ãŠãå士 âç¶æ³ã«å¿ããŠãã¹ã¯ççšã®æšå¥šç¶ç¶ãã¹ãâ
2023幎1æ23æ¥ 21æ05å
ã¢ã¡ãªã«ã§æ°åã³ããã®ææå¯Ÿçãäž»å°ããŠãããã¡ãŠãå士ãNHKã®åç¬ã€ã³ã¿ãã¥ãŒã«å¿ããæ¥æ¬ã§ã¯ãããããã3å¯ãã®åé¿ãšãã¹ã¯ã®ççšãæ¯èŒçãå®çããããšããææå¯ŸçãšããŠæå¹ã ã£ããšè©äŸ¡ããããã§ãä»åŸãç¶æ³ã«å¿ããŠããã¹ã¯ççšã®æšå¥šãç¶ç¶ãã¹ãã ãšæèšããŸããã
ã¢ã¡ãªã«ã®ã¢ã³ãœããŒã»ãã¡ãŠãå士ã¯ãææçç ç©¶ã®ç¬¬äžäººè ã§ãåœæã®ã¬ãŒã¬ã³å€§çµ±é 以éãæŽä»£7人ã®å€§çµ±é ã®ããšã§ææç察çã«åãçµã¿ãå æãŸã§ã¢ã¡ãªã«æ¿åºã®éŠåžå»çé¡§åãšããŠãæ°åã³ããã®ææå¯Ÿçãäž»å°ããŠããŸããã
ãã¡ãŠãå士ã¯ããã®ã»ã©ãNHKã®åç¬ã€ã³ã¿ãã¥ãŒã«å¿ããäžçã®ä»ã®ææç¶æ³ã«ã€ããŠãååœã§ç¶æ³ã¯ç°ãªããšããªããããç§ãã¡ã¯ãŸã ãã³ãããã¯ã®ãŸã£ãã äžã«ããããšããèªèã瀺ããŸããã
æ¥æ¬ã®ãããŸã§ã®æ°åã³ãã察çã«ã€ããŠã¯ãã3å¯ãã®åé¿ãšãã¹ã¯ã®ççšã瀟äŒã®äžã§æ¯èŒçãå®çããããšãæ¥æ¬ã®ææå¯Ÿçã«æå¹ã ã£ãããšè©äŸ¡ããããã§ãã¢ã¡ãªã«ã§ã¯CDCïŒçŸç 察çã»ã³ã¿ãŒãå°åããšã®ææç¶æ³ãªã©ãåºæºã«ãå Žåã«ãã£ãŠã¯å±å ã§ã®ãã¹ã¯ççšãæšå¥šããŠããããšãäŸã«æãããæ¥æ¬ã§ãä»åŸãææç¶æ³ã«å¿ããŠå±å ã§ã®ãã¹ã¯æšå¥šãè¡ãã¹ãã ããšæèšããŸããã
æ°åã³ãããŠã€ã«ã¹ã®æææ¡å€§ã«å¯ŸããWHOïŒäžçä¿å¥æ©é¢ããåœéçã«æžå¿µãããå ¬è¡è¡çäžã®ç·æ¥äºæ ãã宣èšããŠãŸããªã3幎ã«ãªããŸãã
ãã¡ãŠãå士ã¯ãæ°åã³ããã ãã§ãªãæ°ããææçã¯ä»åŸãçºçãç¶ãããšããŠãäžçã¯æ°žç¶çã«èŠæãç¶ããªããã°ãªããªããšããèªèã瀺ããŸããã
ãã®ããã§ãæ°åã³ãããžã®å¯ŸçãšããŠã¯ã¯ã¯ãã³æ¥çš®ãæãæå¹ã ãšããŠããç§ãã¡ã¯äžçäžã§ãã¯ã¯ãã³ããŸã æ¥çš®ããŠããªã人ã ãã§ãªããæ¥çš®ãã人ã«ãææ°ã®è¿œå æ¥çš®ãåããŠãããããããã£ãšåªåããªããã°ãªããªãããšè©±ããŠããŸããã
ä»åŸãããŸã ãŸã ã¯ã¯ãã³ãæ¥çš®ãããããšããŠãããšãšããçºèšã§ãã
ã€ã³ã¿ãã¥ãŒã®è©³çްã¯ãäžèšã«ãããŸãã
æ¥æ¬ã®å¯Ÿçã«ã€ããŠNHKåŽããããææçæ³äžã®äœçœ®ã¥ãã®ç§»è¡ã¯ïŒããå±å ã§ã®ãã¹ã¯ççšæšå¥šã¯ä»åŸã©ããã¹ããããªã©ã®è³ªåãããŠããŸãã
ç°åžžãªã¹ããŒãã§ã¯ã¯ãã³éçºãéå§!?
圌ã®çºèšãNHKãã©ã®ããã«åãäžããŠããããããã®ãŒã£ãŠèª¿ã¹ãŠã¿ãŸããã
2020幎1æ27æ¥
æ°åèºç ææçµè·¯åããã ã¯ã¯ãã³ãç¹å¹è¬ã¯ãªã
2020幎1æ27æ¥ 17æ42å
æ°åã³ãããŠã€ã«ã¹ã¯ããããŸã§ã«ã¯ç¥ãããŠããªãæ°ãã«ç¢ºèªããããŠã€ã«ã¹ã§ãææçµè·¯ãåãã£ãŠããªãã»ãã人é¡ã¯ãã®ãŠã€ã«ã¹ã«å¯Ÿããå ç«ãæããªããšèããããã¯ã¯ãã³ãç¹å¹è¬ã¯ãããŸããã
ïŒäžç¥ïŒ
ã¢ã¡ãªã«åœç«ã¢ã¬ã«ã®ãŒã»ææçç ç©¶æã¯ãæ°åã³ãããŠã€ã«ã¹ã®ã¯ã¯ãã³ã®éçºãé²ããŠããããšãæããã«ããŸããã
ç ç©¶æã®ã¢ã³ãœããŒã»ãã¡ãŠãæé·ã¯ãã¢ã¡ãªã«ã¡ãã£ã¢ã®åæã«å¯ŸããŠãïŒãæä»¥å ã«ã¯ã¯ãã³ã®å¹æãå®å šæ§ã確ãããããã®èšåºè©Šéšãå§ããããšè©±ããŠããŸãã
ïŒä»¥äžç¥ïŒ
2020幎1æ27æ¥ã®èšäºã§ããã§ã«ãïŒãæä»¥å ã«ã¯ã¯ãã³ã®å¹æãå®å šæ§ã確ãããããã®èšåºè©Šéšãå§ããããšèšã£ãŠããŸããã

ãã¡ã€ã¶ãŒç€Ÿè£œã¯ã¯ãã³ã®å¯©æ»å ±åæžã«ã¯ãWHOããã®èºçãæ°åã³ãããŠã€ã«ã¹ã«ãããã®ã ãšçºè¡šããã®ã2020幎1æ12æ¥ã ãšæžããŠãããŸãã
ããããçŽ2é±éåŸã«ã¯ãããã¯ã¯ãã³ã®éçºã«ã€ããŠã3ã¶æä»¥å ããªã©ãšå ·äœçã«èšã£ãŠããã®ã§ãã

ãã¡ã€ã¶ãŒç€Ÿããã€ããã¯ã¯ãã³éçºãããã¯ããæããé»å¡ãã«ãªã£ãŠããŸãããªãé ãå¿ èŠãããã®ãããããŸãããããããã1æãªã®ã§ãããã

äžæ¹ãã¢ãã«ã瀟ã®ã¯ã¯ãã³ã¯ã2020幎1æããéçºãé²ãããã3æã«ã¯èšåºè©Šéšãéå§ãããšæžãããŠããŸãã
ãã¡ãŠãæ°ããã€ããã¯ã¯ãã³éçºã®éå§ã«ã€ããŠè¿°ã¹ãŠããããä»ã®ãã¥ãŒã¹ã調ã¹ãŠã¿ãŸããã
äžèšã®èšäºã«ã¯ã2020幎1æ28æ¥ã®èšè äŒèŠã§ãã®ããšã«è§ŠããããšãæžãããŠããŸãã
US health officials fast-track coronavirus vaccine, hope to start clinical trial in three months
Published Tue, Jan 28 20202:42 PM ESTã
CNBCãã
âIt will take three months to get it into the trial, three months to get safety, immunogenicity data,â Fauci said during a press briefing on the nationâs response to the coronavirus.
ãšãããã1æ23æ¥ã®èšäºã§ããã€ã³ã¿ãã¥ãŒã§åæ§ã®ããšãèªã£ãŠããããšãããããŸããã
Coronavirus Vaccine Candidate Eyed for Human Trials by April (1)
Jan. 23, 2020, 4:28 AM; Updated: Jan. 23, 2020, 5:16 AMã
Bloomberg lawããã
âWeâre already working on it. And hopefully in a period of about three months, weâll be able to start a phase I trial in humans,â Fauci said.
ããã§ã«ã¯ã¯ãã³ã®éçºã«åãçµãã§ãããããŸãããã°ãçŽ 3 ãæä»¥å ã«ãããã§ã®ç¬¬ I çžè©Šéšãéå§ã§ããã ããã
WHOã®çºè¡šã1æ12æ¥ã ã£ãã®ã«ããéçºã«åãçµãã§ãããªããŠãæ©ãããŸãã
ããã«ãã®èšäºã«ã¯ãåœç«ã¢ã¬ã«ã®ãŒã»ææçç ç©¶æïŒNIAIDïŒã¯ãã¢ãã«ã瀟ãšååããŠãããšãããŸããã
The NIAID is collaborating with Moderna Inc., a Cambridge, Mass. biotechnology company, to use its RNA-based vaccine technology to develop a new vaccine.
ã¢ãã«ãç€Ÿãšæ·±ãé¢ããã®ãã人ç©ã«ãNHKã¯ãªããã®ã¿ã€ãã³ã°ã§åç¬ã€ã³ã¿ãã¥ãŒãè¡ã£ãã®ã§ããããã
以åã®èšäºã§æ€èšŒããŸãããã2020幎12æ23æ¥ ã«ãã¡ãŠãæ°ã®ãã¯ã¯ãã³ã®æå¹æ§ãšå®å šæ§ã«çµ¶å€§ãªä¿¡é Œãæã£ãŠããããšããçºèšãå ±ããããããããNHKã¯ã¯ã¯ãã³ã«å¯ŸããŠæ éãªæèŠãåãäžããªããªã£ãŠãããŸããïŒäžèšåç §ïŒã
2023幎ã«ãªãããã£ãšé±åèªãªã©ãã³ããã¯ã¯ãã³æ¥çš®åŸã®æ»äº¡äºäŸãå°ããã€åãäžããããã«ãªã£ãŠããŸããããããªã®ã«ããã®ã¿ã€ãã³ã°ã§ãã¯ã¯ãã³ã®æå¹æ§ãšå®å
šæ§ã«çµ¶å€§ãªä¿¡é Œãæã£ãŠããã人ç©ã«ã€ã³ã¿ãã¥ãŒãããªããŠãNHKã¯ãã€ãŸã§åã£ãå ±éãç¶ããã®ã§ããããã
éå£å ç«ã«é¢ãããã¡ãŠãæ°ã®çºèš
ããã«æãèµ·ãããŠãããšãéå£å ç«ã«é¢ããŠæ°ã«ãªãçºèšããããŸããã
éå£å ç«ã人å£ã®70ïœ90ïŒ ãå ç«æã€å¿ èŠãç±³æ¿åºã³ããå°éå®¶
2020幎12æ25æ¥ 18æ51å
ã¯ã¯ãã³ãªã©ã«ãã£ãŠã人å£ã®ã©ãããããå ç«ãæãŠã°ææãåºããã«ãããªããéå£å ç«ããšåŒã°ããç¶æ ã«ãªãã®ãã«ã€ããŠãã¢ã¡ãªã«æ¿åºã®æ°åã³ãããŠã€ã«ã¹å¯ŸçããŒã ã®ãã¡ãŠãå士ã¯ãæåçŽãã¥ãŒãšãŒã¯ã»ã¿ã€ã ãºã®ã€ã³ã¿ãã¥ãŒã§ãæ£ç¢ºã«ã¯åãããªããã70ïŒ ãã90ïŒ ã®éã ãšæãããšè¿°ã¹ã人å£ã®7å²ä»¥äžãå ç«ãæã€å¿ èŠããããšããèŠæ¹ã瀺ããŸããã
å€ãã®äººãå ç«ãæã€ããã«ãªãããšã§ææãåºããã«ãããªããéå£å ç«ãã«ã€ããŠããã¥ãŒãšãŒã¯ã»ã¿ã€ã ãºã¯ããã¡ãŠãå士ã®ã€ã³ã¿ãã¥ãŒèšäºã24æ¥ã®é»åçã«æ²èŒããŸããã
ïŒä»¥äžç¥ïŒ
ã¢ã¡ãªã«ã§ã³ããã¯ã¯ãã³ã®æ¥çš®ãå§ãŸã£ãã®ã¯ã2020幎12æ14æ¥ã§ããéå§ããŠ10æ¥ã»ã©ã§ããã®ãããªçºèšãããŠããŸããã
äžæ¹ãéå£å ç«ã«ã€ããŠãååŽçã¯äžèšã®ããã«èª¬æããŠããŸãã

éå£å ç«å¹æãèŠãããããã«ã¯ãã¯ã¯ãã³èªäœã«ææ/çºçäºé²å¹æãããããšãåæã§ããããã©ãæ°åã³ããã§ã¯ææäºé²å¹æã®å®èšŒã¯ã»ãŒäžå¯èœãšèãããããšèšã£ãŠããŸãããã®è³æã¯äœåºŠãç»å ŽããŸãããããã¯2020幎8æ21æ¥ã®è³æã§ãã
ãŸããååŽçHPã®Q&Aã«ããäžèšã®ããã«æžãããŠããŸãã

ãªããææçã®çš®é¡ã«ãã£ãŠãéå£å ç«ãåŸãããã«å¿ èŠãªå ç«ãæã€äººã®å²åã¯ç°ãªããŸãããŸããã¯ã¯ãã³ã«ãã£ãŠã¯ãæ¥çš®ã§éçåãé²ã广ããã£ãŠãææãé²ã广ãä¹ãããã©ãã ãå€ãã®äººã«æ¥çš®ããŠãéå£å ç«ã®å¹æãåŸãããªãããšããããŸãã
æ°åã³ããã¯ã¯ãã³ã«ãã£ãŠãéå£å ç«ã®å¹æããããã©ããã¯åãã£ãŠããããåãããŸã§ã«ã¯ãæéãèŠãããšèããããŠããŸãã
ã©ã®æç¹ã§ã®æ å ±ãå¹Žææ¥ãæžãããŠããŸãããããéå£å ç«ã®å¹æããããã©ããã¯åãã£ãŠããããåãããŸã§ã«ã¯ãæéãèŠãããšèããããŠããŸãããšæžããŠãããŸãã
ããã©ãããã€ã®ãŸã«ããéå£å ç«ããæ¥çš®ã®å£²ãæå¥ã«ãªã£ãŠãããŸããããã¿ããªã®ãããã«ãªããªããŠãèšåºè©Šéšã§ã¯èª¿ã¹ãŠãããªãããã¯ã¯ãã³ã®æ·»ä»ææžã«ãæžãããŠããªãã®ã«ã

å°æ¹èªæ²»äœã®ãã©ã·ããååŽçã¯ãã§ãã¯ããªãã®ã§ãããããããŠã€ã«ã¹ãå®å
šã«çµæ¯ãããããªããŠãå®å
šã«ã¢ãŠãã ãšæããŸãã

è£é¢

æ¡å€§

æ·»ä»ææžã«ãªã广ãããããæžãããŠããŸããïŒäžèšåç §ïŒããéŠå·ç調æ»ããšã¯ã©ã®ãããªãã®ãæ°ã«ãªããŸãã
远èšïŒ2023幎1æ30æ¥
ãéŠå·ç調æ»ãã«ã€ããŠèª¿ã¹ãŸããã
å€ãã®å°æ¹èªæ²»äœã¯éå£å ç«ãšããå¹»æ³ãæ±ãããã瀟äŒã®ããããã¿ããªã®ããããšãã衚çŸã䜿ã£ãŠäººã ãæ¥çš®ãžãšèªå°ããŠãããŸããã
ããã©ã2021幎9æ3æ¥ã«ã¯ãéå£å ç«ã®ç²åŸã¯å°é£ã ãšãæ°åã³ãããŠã€ã«ã¹ææç察çåç§äŒãèªããŠããŸãã
ã¯ã¯ãã³æ¥çš®ãé²ãäžã§æ¥åžžç掻ã¯ã©ã®ããã«å€ããåŸãã®ãïŒ
什åïŒå¹ŽïŒæïŒæ¥ïŒéïŒãæ°åã³ãããŠã€ã«ã¹ææç察çåç§äŒ

äžèšã®çç±ã諞å€åœã®ç¥èŠãèžãŸãããšãæãåœã«ãããŠå šãŠã®åžæè ãã¯ã¯ãã³æ¥çš®ãçµãããšããŠãã瀟äŒå šäœãå®ããããšããæå³ã§ã®éå£å ç«ã®ç²åŸã¯å°é£ãšèããããã
ååŽçã¯ãããããªãããšããŠããã®ã«ããªãNHKã¯ãã¡ãŠãæ°ã®çºèšã ããå ±ããã®ã§ããããã
ãã®èšäºã«åºãŠãããã¥ãŒãšãŒã¯ã»ã¿ã€ã ãºã®å
èšäºïŒHow Much Herd Immunity Is Enough?ãDec. 24, 2020ïŒã«ã¯ãäžèšã®ããã«æžãããŠããŸããã
â»äžèšããé£ã¶ãšç»é²ç»é¢ãã§ãŠããŸããŸããããHow Much Herd Immunity Is Enough?ãã§æ€çŽ¢ããŠé£ã¶ãšãæ®éã«èªããããã§ãã
The Centers for Disease Control and Prevention offers no herd immunity estimate, saying on its website that âexperts do not know.â
ãã¢ã¡ãªã«ã®CDCïŒçŸç äºé²ç®¡çã»ã³ã¿ãŒïŒã¯ãå°éå®¶ã«ãããããªããšãéå£å ç«ã®æšå®å€ãWebãµã€ãã§æäŸããŠããªãã
ããã«ãã®åŸã®èšè¿°ã§ãWHOã®äºé²æ¥ç𮿠åœDr. Katherine OâBrienã¯ã âWe should say we just donât know. ïŒããããªããšããèšãã¹ãã§ã¯ãªãïŒâãšèšã£ãŠããã®ã§ããéå£å ç«ã«ã€ããŠã€ã³ã¿ãã¥ãŒããä»ã®ç«åŠè ãããåçã¯æšæž¬ã«éããªãããšåŒ·èª¿ããŠããŸããã
NHKã¯ãããã«ã¯è§Šããããã¡ãŠãæ°ã®çºèšã ããåãäžããŠããŸããããã¥ãŒãšãŒã¯ã»ã¿ã€ã ãºã®å šæãèªããšãNHKã®èšäºãšã¯å°è±¡ãããªãéããŸãã
æ¥æ¬ã«ã¯ã¯ãã³è£œé æ ç¹ãäœãçããšã¯ïŒ
2022幎5æã«ãNHKã¯ãã¡ãŠãæ°ã«ã€ã³ã¿ãã¥ãŒãè¡ã£ãŠãããè¿œå æ¥çš®ã«ã€ããŠäžèšã®ããã«èšã£ãŠããŸãã
ç±³ãã¡ãŠãå士 âä»åŸå¹ åºã幎代ã«ã¯ã¯ãã³è¿œå æ¥çš®ãå¿ èŠâ
2022幎5æ19æ¥ 7æ27å
ã¢ã¡ãªã«æ¿åºã®æ°åã³ãããŠã€ã«ã¹å¯Ÿçãäž»å°ããŠããã¢ã³ãœããŒã»ãã¡ãŠãå士ã¯18æ¥ãNHKã®ã€ã³ã¿ãã¥ãŒã«å¯Ÿããããšãã®ç§ä»¥éã«ææãæ¡å€§ããäºæ ã«åããããå¹ åºã幎代ã®äººã«ã¯ã¯ãã³ã®è¿œå æ¥çš®ãå¿ èŠã«ãªããšããèŠæ¹ã瀺ããŸããã
ïŒä»¥äžç¥ïŒ
ãããŠ2022幎9æã«ã¯ã5æ³ïœ11æ³ã®åã©ãã«ãè¿œå æ¥çš®ãè¡ãããããã«ãªããŸããã
æåã®èšäºã«æ»ã£ãŠã¿ããšããã¡ãŠãæ°ã¯NHKã®åç¬ã€ã³ã¿ãã¥ãŒã«å¿ããã¯ã¯ãã³ã«ã€ããŠäžèšã®ããã«èšã£ãŠããŸãã
2023幎1æ23æ¥ã®èšäº
æ°åã³ãããžã®å¯ŸçãšããŠã¯ã¯ã¯ãã³æ¥çš®ãæãæå¹ã ãšããŠããç§ãã¡ã¯äžçäžã§ãã¯ã¯ãã³ããŸã æ¥çš®ããŠããªã人ã ãã§ãªããæ¥çš®ãã人ã«ãææ°ã®è¿œå æ¥çš®ãåããŠãããããããã£ãšåªåããªããã°ãªããªãããšè©±ããŠããŸããã
ãã¡ãŠãæ°ãšååããŠã¯ã¯ãã³éçºãè¡ã£ãŠããã¢ãã«ã瀟ã¯ãæ¥æ¬ã«ã¯ã¯ãã³è£œé æ ç¹ãäœãããšããŠããŸãã
2022幎9æ15æ¥ã®èšäº
NHKããã¢ã¡ãªã«ã®æ¿åºè·ãéä»»ãããã¢ãã«ãç€Ÿãšæ·±ãé¢ããããã人ç©ã®ã€ã³ã¿ãã¥ãŒããã®ã¿ã€ãã³ã°ã§è¡ãããã¯ã¯ãã³ããŸã æ¥çš®ããŠããªã人ã ãã§ãªããæ¥çš®ãã人ã«ãææ°ã®è¿œå æ¥çš®ãåããŠãããããããã£ãšåªåããªããã°ãªããªãããšããçºèšãããããåœæ°ã«äŒããŠããã®ã§ãããããŸã§ã®æµããèããŠãããã ã®ã€ã³ã¿ãã¥ãŒèšäºãšããŠèªã¿æµãã¹ãã§ã¯ãªãããã«æããŸãã
